Almirall SA (id:4682 ALM)
8.15 EUR
Opening hours: 09:00 - 17:30 (Central European Standard Time: 12/24/2024 6:31:53 PM)
Exchange closed, opens in 14 hours 28 minutes
About Almirall SA
Market Capitalization 1.79B
Almirall, S.A., a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, respiratory, and nervous system; dermatologicals; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. It has a multi-target alliance with Etherna to research and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.
| Headquarters (address) |
Ronda General Mitre, 151 Barcelona 08022 Spain |
| Phone | 34 93 291 30 00 |
| Website | https://www.almirall.com |
| Employees | 2K |
| Sector | Healthcare |
| Industry | Drug Manufacturers Specialty & Generic |
| Ticker | ALM |
| Exchange | Madrid Stock Exchange |
| Currency | EUR |
| 52 week range | 7.85 - 10.04 |
| Market Capitalization | 1.79B |
| Dividend yield forward | 9.01 % |
| Dividend yield forward Spain (ID:221, base:120) | 11.71 % |
| P/E trailing | 57.53 |
| P/E forward | 18.22 |
| Price/Sale | 1.87 |
| Price/Book | 1.22 |
| Beta | 3.00 |
| EPS | 3.00 |
| EPS Spain (ID:221, base:143) | 3.00 |
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Almirall SA has raised their dividend 9.01 years in a row. This is below the 42122.092800 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Almirall SA has raised their dividend 3.00 years in a row. This is below the 12.560500 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Almirall SA has raised their dividend 1.86 years in a row. This is below the 10.207200 year average in the 'Drug Manufacturers Specialty & Generic' industry
Payout Ratio
Payout Ratio: Almirall SA has raised their dividend 116.25 years in a row. This is below the 148.467900 year average in the 'Drug Manufacturers Specialty & Generic' industry
Self funded year
Almirall SA years needed to self fund. This is above the 34.112811 year average in the 'Drug Manufacturers Specialty & Generic' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Almirall SA has raised their dividend 9.01 years in a row. This is below the 42122.092800 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Almirall SA has raised their dividend 3.00 years in a row. This is below the 12.560500 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Almirall SA has raised their dividend 1.86 years in a row. This is below the 10.207200 year average in the 'Drug Manufacturers Specialty & Generic' industry
Payout Ratio
Payout Ratio: Almirall SA has raised their dividend 116.25 years in a row. This is below the 148.467900 year average in the 'Drug Manufacturers Specialty & Generic' industry
Self funded year
Almirall SA years needed to self fund. This is above the 34.112811 year average in the 'Drug Manufacturers Specialty & Generic' industry